levosimendan (Simdax)

From Aaushi
Jump to navigation Jump to search

Contraindications

* may diminish likelihood of successful weaning from ventilator

Dosage

  • 0.05 to 0.2 ug/kg/min

Mechanism of action

More general terms

References

  1. Gordon AC et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016 Oct 5 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27705084 Free Article
  2. 2.0 2.1 PubChem: 3033825
  3. 3.0 3.1 Mehta RH, Leimberger JD, van Diepen S et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 2017 Mar 19 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28316276 Free Article <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1616218
  4. 4.0 4.1 Landoni G, Lomivorotov VV, Alvaro G et al. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 2017 Mar 21 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28320259 Free Article <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1616325

Database